Demmler N
Klin Monbl Augenheilkd. 1983 Feb;182(2):153-5. doi: 10.1055/s-2008-1054735.
This paper presents the results of a study on the effect of Metipranolol eye drops (Betamann) in 10 patients. The drops were tested with the following forms of glaucoma: glaucoma associated with alpha-kia, neovascular glaucoma, exfoliative glaucoma, pigmentary glaucoma, juvenile glaucoma. Some patients required treatment in combination with miotics. Metipranolol eye drops reduced intraocular pressure by about 15 percent for a prolonged period of time. The pressure-lowering effect was maintained during an observation period of twelve months. Visual acuity and visual fields were constant. The drug was tolerated well subjectively by almost all the patients.
本文介绍了一项关于美替洛尔滴眼液(倍他洛尔)对10例患者疗效的研究结果。该滴眼液针对以下几种青光眼进行了测试:与α-晶状体蛋白相关的青光眼、新生血管性青光眼、剥脱性青光眼、色素性青光眼、青少年性青光眼。部分患者需要联合缩瞳剂进行治疗。美替洛尔滴眼液可使眼压在较长时间内降低约15%。在12个月的观察期内,眼压降低效果持续存在。视力和视野保持稳定。几乎所有患者对该药物的耐受性良好。